Purpose To compare two vitrification methods and two warming methods for human oocyte vitrification using a high security closed device in terms of survival, fertilization and embryo development. Methods For vitrification, oocytes were (1) immediately placed in equilibration solution or (2) they were gradually exposed to the cryoprotectants. For warming, oocytes were placed (1) in a 25 μl preheated (37°C) thawing solution droplet that was put at room temperature for 1 min once the oocytes were inside or (2) in a 150 μl droplet for 1 minute at 37°C. Results Survival and preimplantation development were significantly lower when warming was performed in a small preheated droplet. There was no significant difference in survival and embryo development between the gradual or direct exposure to cryoprotectants. Conclusions Using this high security closed vitrification device a 90 % survival rate can be achieved when the oocytes are immediately warmed in a large volume at 37°C.
Introduction
Oocyte cryopreservation for women in their reproductive age opens new opportunities in IVF because: (i) it permits women to cryopreserve oocytes prior to gonadotoxic radio-or chemotherapy and ovariectomy [3, 60] , (ii) it allows women to delay childbearing [58] , (iii) it eliminates donor-recipient endometrium synchronization problems and (iv) it avoids ethical and legal concerns regarding supernumerary cryopreserved embryos and embryo ownership [53] .
Since the first report of a pregnancy from a frozenthawed human oocyte in 1986 [11] , oocyte cryopreservation has gained increasing interest. Although slow-freezing protocols for oocytes have been modified and improved over time, the outcomes are variable and difficult to reproduce [8, 13, 22, 39, 42, 44, 45, 57, 67] . A consensus has slowly emerged stating that vitrification procedures result in a better embryological and clinical outcome than the slowfreezing procedures [9, 12, 18, 24, 34, 35, 42, 55, 56] . The applied vitrification procedure combines ultra rapid cooling/ warming with high cryoprotectant concentrations and minimal volume methods [29] [30] [31] . Hence, the surrounding solution is solidified in an amorphous glass-like structure avoiding ice crystal formation [19] . Today, vitrification of oocytes can result in >90 % survival rate, with fertilization (>75 %) and pregnancy rates (32-65 % per embryo transfer) similar to fresh oocytes [3, 15, 40] . Open storage devices -generating a higher cooling rate than closed devices-have been used preferentially, however cross-contamination during vitrification and liquid nitrogen storage cannot be excluded [4, 5, 23, 61] . Bielanski et al. [4] reported that the CBS High Security (HS) Straws (CryoBioSystem, Paris, France) are optimal devices for cryopreservation because they are impermeable to pathogenic agents and resistant to extremely low temperature.
Since the implementation of the EU Cell and Tissue Directive in Belgium, national guidelines encourage to use the CBS-VIT HS system for oocyte and embryo vitrification in order to prevent cross-contamination [58, 63] .
Special attention should be paid to oocyte cryopreservation procedures since oocytes are particularly susceptible to cryodamage due to their large surface/volume ratio, plasma membrane permeability properties [47] and intracellular functions (calcium, ribosomes, Golgi apparatus, mitochondria, intracellular trafficking of molecules and organelles) [56] . Moreover, the meiotic spindle, necessary for the correct completion of meiosis and fertilization, is very sensitive to chemical and physical changes. The microtubular structure of the meiotic spindle is affected when oocytes are cooled to room temperature, with a potential deleterious consequences on chromosomal organization [48] . The Polscope, a non-invasive computer-assisted polarized light microscopy system, can be used to study spindles in oocytes [64] [65] [66] . The presence of the spindle is suggested to be linked to higher fertilization rates [65, 66] and a higher proportion of good quality embryos [37] . On the other hand, the inability to detect meiotic spindles in oocytes is associated with a higher incidence of fertilization and cleavage abnormalities [49] .
The present study aimed to compare two vitrification methods and two warming methods for human oocyte vitrification in a high security closed system in terms of survival, fertilization and blastocyst formation. In two experiments, two vitrification methods and two warming methods were compared on mature sibling oocytes that were donated for research.
Materials and methods

Oocyte source
Human oocytes were used to create embryos for research in our centre. For this study, approval of the Local Ethical Committee of UZ Brussel and the Federal Committee for medical and scientific research on human embryos in vitro was obtained. Oocytes were obtained from couples suffering from severe male factor infertility who were unable to undergo ICSI due to the lack of sperm in their testicular biopsy. Oocyte cryopreservation or the use of donor sperm was not an option for them and they donated their oocytes to create embryos for research after written informed consent. Before vitrification, oocytes were denuded with Cumulase® (80 USP Units/ml, Halozyme Therapeutics Inc., San Diego, CA, USA) from surrounding cumulus and corona cells [17] . Depending on the number of oocytes available per patient, oocytes were vitrified individually or per two.
Vitrification method 1 (V1)
Denuded oocytes were placed in a pre-equilibrated (37°C) 25 μl droplet HTF-hepes supplemented with Human Serum Albumin (HSA, Vitrolife, Sweden) at 37°C for 1 min. Subsequently, they were equilibrated in a 25 μl ES droplet for 10 min at room temperature (RT). Then they were placed in four consecutive 25 μl VS droplets at RT and loaded on the CBS vit straw within 60 s. Straws were thermosealed before plunging into liquid nitrogen.
Vitrification method 2 (V2)
Oocytes were placed in a pre-equilibrated (37°C) droplet of 25 μl HTF-hepes supplemented with HSA and put at RT for 1 min once the oocytes were inside. After 1 min, this droplet was merged with 25 μl ES for 2 min at RT followed by a second merging with 25 μl ES for 2 min. Then oocytes were transferred to a new 25 μl ES droplet for 10 min, followed by four consecutive 25 μl VS droplets and they were loaded on the CBS vit straw within 60 s. Straws were thermosealed before plunging into liquid nitrogen.
The most important difference between the two vitrification methods is the way the oocytes are exposed to the cryoprotectants. In V1, oocytes are directly exposed to cryoprotectants by putting the oocytes immediately in ES. In V2, oocytes undergo a gradual exposure by merging the HTF-hepes droplet twice with the same volume of ES.
Warming method 1 (W1)
A 25 μl TS droplet was preheated at 37°C. The dish was put at RT to put the oocytes into the droplet; they were kept at RT for 1 min. This was followed by a second incubation in TS at RT for 1 min. Oocytes were then placed twice in 25 μl DS at RT for 2 min. Finally, three washes of 3 min each were performed in 25 μl WS at RT.
Warming method 2 (W2)
Oocytes were immediately placed in 150 μl preheated TS at 37°C for 1 min, followed by 3 min in 25 μl DS and two washes for 5 min each in 25 μl WS, both at RT.
The major difference between the two warming methods is the warming rate achieved during the first warming step. In W1, oocytes were places in a small (25 μl) pre-heated (37°C) TS droplet that was put at RT to put the oocytes inside. In W2, oocytes were places in a large (150 μl) preheated (37°C) TS droplet that was kept at 37°C.
After washing, oocytes were transferred to individual 25 μl droplets of fertilization medium (Sage, Cooper Surgical) under oil and scored for survival. Subsequently, they were cultured for 2 h in an incubator with 5 % O 2 and 6 % CO 2 .
In experiment 1, V1 was combined with W1 and W2. In experiment 2, V1 and V2 were combined with W2.
Evaluation of survival
Warmed oocytes were considered 'morphologically surviving' if there was no dark/degenerated or contracted ooplasm and no cracked zona pellucida.
Polscope analysis
In experiment 2, the presence of the spindle was analysed at 0, 1 and 2 h post-warming using the Polscope imaging system (Research Instruments). Oocytes were placed in a 5 μl drop of HTF-hepes under oil in a glass-bottom culture dish, pre-heated at 37°C (WillCo-dish, Amsterdam, The Netherlands). An inverted microscope with Polscope equipment and liquid crystal compensator optics (SpindleView, CRI, Cambridge, USA) combined with a computerized image-analysis system (SpindleView Software; CRI) was used at 200x magnification to examine the re-appearance of the spindle on a heating stage at 37°C.
Fertilization and embryo quality
After 2 h incubation in fertilization medium, ICSI was performed on all surviving oocytes [62] with sperm of a consenting donor. The injected oocytes were cultured in individual 25 μl droplets of cleavage medium (Sage, Cooper Surgical) under oil (Vitrolife) until day 3 and further cultured in blastocyst medium (Sage, Cooper Surgical) until day 5-6.
Fertilization was checked 17-19 h after injection. Preimplantation embryo development was evaluated daily. Good-quality day 3 embryos were defined as having at least six blastomeres and <20 % fragmentation. Blastocyst evaluation relied on the scoring system described by Gardner and Schoolcraft [20] : good-quality blastocysts were defined as being a full blastocyst with an ICM and a TE of type A or B on day 5 or day 6.
Blastocyst fixation, immunostaining and confocal microscopy
All good-quality blastocysts were fixed for further immunofluorescent analysis as described by Cauffman et al. [10] . Immunofluorescent staining with NANOG and KRT-18 was performed to check the quality of the blastocysts. NANOGpositive nuclei should be restricted to the ICM cells. KRT-18 should abundantly be present in the TE and reflect the integrity of the epithelium. Fixation was performed on day 5 or 6 depending on the blastocyst developmental rate and quality. Blastocysts were individually stained in 50 μl droplets in a 96-well plate (650185, Cellstar, Greiner Bio-one, Frickenhausen, Germany). Fixation was performed with 3.7 % formaldehyde (Merck, Darmstadt, Germany) at RT for 10 min and was followed by permeabilization with 0.1 % Triton X-100 (Sigma-Aldrich, St Louis, MO, USA) at RT for 20 min. Both solutions were made in phosphate-buffered saline (PBS). Samples were incubated overnight at 4°C with a rabbit polyclonal IgG antibody against NANOG (3 μg/ml; ab21624, Abcam, Cambridge, UK) and KRT18 (1 μg/ml; ab668, Abcam). Control reactions for the nonspecific binding of the primary antibodies were included in each experiment and carried out by replacing the rabbit antibodies with rabbit serum (R9133, Sigma-Aldrich, St Louis, MO, USA) and the mouse antibodies with mouse IgG1s (349040, Becton Dickinson, Franklin Lakes, NJ, USA) under the same conditions as the primary antibodies. Alexa Fluor® 488 F(ab′)2 fragment of goat anti-rabbit IgG (H+L) (A-11070, Molecular Probes, Invitrogen, Stockholm, Sweden) and Alexa Fluor® 647 F(ab′)2 fragment of goat anti-mouse IgG (H+L) (A-21237, Molecular Probes) were used as secondary antibodies. Samples and controls were incubated at a concentration of 10 μg/ml at RT in the dark for 2 h. All antibody solutions were prepared in PBS supplemented with 2 % bovine serum albumin (BSA) (SigmaAldrich). Extensive washing with PBS+2 % BSA was performed between all steps. After staining, blastocysts were put in 0.5 μl SlowFade® Gold antifade reagent with DAPI (S36939, Invitrogen) and were put between two glass cover slips (24×50 mm). To prevent squeezing, round glass cover slips (Ø 10 mm) were put between the cover slips using acrytol mountant (01721, Surgipath Europe LTD, Bretton). Before examination, samples were put at 4°C in the dark for at least 30 min.
Confocal scanning microscopy was performed with a LD-Ar-HeNe laser (405/488/633) (IX71 Fluoview 300; Olympus, Aartselaar, Belgium) to record the fluorescent images. Control and test images were captured using identical settings. Scans were made every 2-2.5 μm for the samples and every 5 μm for the controls throughout the whole blastocyst.
Statistical analysis
Differences between sibling oocytes were assessed by the Wilcoxon Signed-Rank test. A difference was considered statistically significant when the P-value was <0.05.
Results
We started oocyte vitrification in our lab in 2008. Due to the lack of a standardized protocol for aseptic oocyte vitrification at that time, we applied the technique for blastocyst vitrification (V1W1) since this methodology was well-known and successful for blastocysts in our hands [63] . This technique was applied as the starting point for oocyte vitrification from which further improvements were made in two experiments (Fig. 1) .
Experiment 1
In experiment 1, 92 oocytes were vitrified using V1. Forty-four oocytes were warmed with W1 and 48 oocytes with W2 (Table 1) . A significant difference was observed comparing W1 with W2 for survival, fertilization rates, the proportion of good-quality day 3 embryos and good-quality blastocysts on day 5+6. The quality of the blastocysts was confirmed by confocal scanning microscopy; good-quality blastocysts showed a well-formed KRT-18 positive TE and an ICM with cells displaying NANOG (1-31 cells) (Fig. 2) .
Fertilization and embryo development were compared for 26 V1W2 oocytes and 63 fresh sibling oocytes that had been used for other experimental purposes (Table 2) . In this subanalysis, no statistical differences were found. To further increase the survival and developmental rate of the vitrified oocytes, the effect of merging the droplets during vitrification was investigated by gradually exposing the oocytes to the cryoprotectants. Forty-one sibling oocytes were vitrified with V1 (n=20) or V2 (n=21) and all oocytes were warmed with W2 (Table 3) . Survival and fertilization rates and the proportion of good-quality day 3 embryos, good-quality blastocysts on day 5 and good-quality blastocysts on day 5+6 were not different between the two vitrification methods. The presence of NANOG and KRT-18 was confirmed in the blastocysts (data not shown).
Polscope analysis was performed on all surviving oocytes at 0, 1 and 2 h after warming. The results are shown in Table 4 . There was no statistical significant difference between V1 and V2 in spindle re-appearance of the surviving oocytes for the different time points: in both V1 and V2, normal fertilization seemed to be higher when the spindle was present (85 % and 81 % respectively); when the spindle was absent fertilization was 60 % and 0 % respectively. The percentage of good-quality blastocysts per surviving oocyte was 46 % and 50 % respectively when the spindle was present; and 20 % and 0 % respectively when the spindle was absent. Abnormal fertilization was only observed for one oocyte; in this case the spindle was not present before injection.
Discussion
The aim of this study was to compare two vitrification and two warming procedures for mature human oocyte cryopreservation in a high-security closed system in terms of survival and in vitro developmental competence. Although the numbers are small, we conclude that gradual exposure to cryoprotectants by consecutive merging of the ES droplets during vitrification most likely does not provide any added value to the survival and in vitro competence as compared to direct exposure. However, survival of oocytes was higher (90 %) when put immediately in a large droplet of TS at 37°C during warming.
During the last decade, the results obtained with oocyte vitrification have improved to a level almost equal to fresh oocytes. Survival rates over 90 % and fertilization rates ranging between 70 and 95 % led to a tremendous increase in clinical outcome. Most of these results are obtained using open devices for cryostorage [1, 2, 14, 15, 26, 27, 30, 33, 50, 51, 53, 68] .
Currently, only few reports are available with the use of closed systems for oocyte vitrification [7, 22, 41, 43, 46, 55, 58] . Although acceptable survival (57.9 % to 100 %) and fertilization (57.6 % to 77.5 %) rates have been achieved with closed devices, the overall clinical pregnancy rates per warmed oocyte only ranges from 1.5 % to 10 %, while with open devices the live birth rate per warmed oocyte ranges between 1 % and 22 % [15] . This has been attributed to the higher cooling rate in open devices due to the direct contact of the samples with liquid nitrogen [7, 35, 52] , thereby preventing chilling injury [19, 32, 61] . A few studies comparing open and closed devices for oocyte vitrification obtained similar results with both devices ( [7, 61] , indicating that the minor differences in cooling rate might not be so important and that the warming rate could be more important than the cooling rate. Seki and Mazur [54] and Mazur and Seki [36] emphasized this in their experiments: the highest survival rates were obtained when the highest warming rate was used, independent of the initial cooling rate. During slow warming, there is more time for recrystallization which may lead to irreversible damage to the oocyte. Boldt [6] suggested that devitrification and subsequent ice nucleation during warming can be prevented by increasing the warming rate through (i) the use of very small volumes and (ii) plunging directly from LN 2 in 37°C. The latter may explain the differences in oocyte survival in experiment 1 when comparing two different warming methods. The use of a droplet of 150 μl preheated TS at 37°C that is kept at 37°C generated a warming rate sufficiently high to obtain a high survival rate (90 %). Apparently, the warming rate was too slow in the 25 μl droplet that was put at RT. Moreover, fertilization rate and embryo developmental rate were also impaired after thawing in a small droplet at RT, indicating that the quality of the survived oocytes is affected by the warming procedure. To further improve the outcome, the effect of gradually exposing the oocytes to the cryoprotectant during vitrification, in order to reduce the osmotic shock, was investigated (experiment 2). Although investigated on a small number of oocytes, merging droplets during vitrification did not further improve the survival, fertilization and in vitro developmental rates. When looking at the timing of spindle re-appearance after warming, no difference between the two vitrification methods was observed. Because of technical problems with the Polscope, the spindle appearance was not analysed prior to vitrification. However, the results of spindle re-appearance of the warmed oocytes in experiment 2 were higher (72.2-88.9 %) than the range reported for the presence of a spindle in fresh oocytes (53.8-83.5 %), [37, 49, 65, 66] ), indicating that the high security closed vitrification system is safe at this level. As reported by Moon et al. [37] , the embryo developmental rate was higher when the spindle was present. The results of the present study might have been compromised by the large interval between oocyte retrieval and vitrification. In clinical practice, oocytes are vitrified within 1 h after retrieval. However, this strict timing was not possible with the present oocytes due to the time required to search for sperm in the testicular biopsies. The oocytes only became available for research when no sperm was found in the treatment cycle for the couple. This interval was on average 7 h after retrieval and accordingly, injection post-warming was performed on aged oocytes. Taking into account that aged oocytes show a decreased fertilization and preimplantation development [21, 28] , the use of less in vitro aged oocytes for cryopreservation might even improve the results.
In most literature reports, transfers of embryos derived from vitrified/warmed oocytes are performed on day 2 or 3 and extended culture up to day 5 is rarely performed. Goodquality day 3 embryo formation rate per fertilized oocyte ranges between 39.9 % and 96.7 % [1, 2, 14, 33, 51, 53] for open devices and between 57.1 % and 66.7 % [39, 41, 59] for closed devices. In our experiments with W2, goodquality day 3 embryo formation rate up to 76.9 % was achieved, comparable to the results obtained with the fresh oocytes (65.3 %) for research in this study. The implantation potential of the blastocysts could not be evaluated because they were created for research. However they showed a nice ICM with NANOG-positive nuclei and a cohesive TE epithelium expressing KRT18, confirming their viability and potential to develop beyond day 3. Besides this, the fertilization and embryo development rate obtained in this study were comparable with fresh sibling oocytes.
Notwithstanding the lower cooling rate as compared to open devices, closed devices have the major advantage of totally eliminating the risk of cross-contamination [4, 5] , and hereby avoiding the need for special equipment to sterilize the LN2, to use vapour phase nitrogen [16] or hermetical cryostorage [46] .
Even after the delivery of many healthy babies after oocyte vitrification, it remains important to further test the safety of the oocyte vitrification procedures [25, 38] . Regardless of the vitrification system used, it is important to determine the effect of shrinkage and re-expansion on cellular structures and organelles; and its impact on intracellular trafficking and epigenetic modifications [56] .
Based upon the results of this study and using the vitrification solutions and devices described herein, we have found that vitrification of mature human oocytes in a high security closed system is a promising approach. An important step in order to obtain high survival, fertilization and subsequent embryo development in vitro is the first warming step which should be performed in a large droplet at 37°C; the outcome is most likely independent of the direct or gradual exposure to cryoprotectants during vitrification. 
